Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: Suppression by conjugated linoleic acid

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 7, 2006, Pages 793-801

  Sneddon, Alan A ^a   McLeod, Ewan ^a   Wahle, Klaus W J ^b   Arthur, John R ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

Cell adhesion; CLA; Inflammation; PAF antagonist; Phospholipid; PUFA

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; CONJUGATED LINOLEIC ACID; CYTOKINE; GINKGOLIDE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; POLYUNSATURATED FATTY ACID; PROTEIN SYNTHESIS INHIBITOR; SANGUINARINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; ISOMER; PRIORITY JOURNAL; REGULATORY MECHANISM; VASCULAR ENDOTHELIUM;

CELL ADHESION; CELL COMMUNICATION; CELLS, CULTURED; DITERPENES; ENDOTHELIUM, VASCULAR; GINKGOLIDES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; LACTONES; LINOLEIC ACIDS, CONJUGATED; MONOCYTES; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PYRIDINIUM COMPOUNDS; RECEPTORS, G-PROTEIN-COUPLED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33746287145     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.05.014     Document Type: Article

References (43)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Springer T.A. Adhesion receptors of the immune system. Nature 346 (1990) 425-434
3. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab. Invest. 68 (1993) 499-508
4. Carlos T., Kovach N., Schwartz B., Rosa M., Newman B., Wayner E., Benjamin C., Osborn L., Lobb R., and Harlan J. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77 (1991) 2266-2271
5. Andrew D.P., Spellberg J.P., Takimoto H., Schmits R., Mak T.W., and Zukowski M.M. Transendothelial migration and trafficking of leukocytes in LFA-1-deficient mice. Eur. J. Immunol. 28 (1998) 1959-1969
6. Meerschaert J., and Furie M.B. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J. Immunol. 154 (1995) 4099-4112
7. Muller W.A., Weigl S.A., Deng X., and Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178 (1993) 449-460
8. Weber C., and Springer T.A. Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration. J. Immunol. 161 (1998) 6825-6834
9. Zimmerman G.A., McIntyre T.M., Mehra M., and Prescott S.M. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J. Cell Biol. 110 (1990) 529-540
10. Zimmerman G.A., McIntyre T.M., and Prescott S.M. Adhesion and signaling in vascular cell-cell interactions. J. Clin. Invest. 98 (1996) 1699-1702
11. Mayer K., Merfels M., Muhly-Reinholz M., Gokorsch S., Rosseau S., Lohmeyer J., Schwarzer N., Krull M., Suttorp N., Grimminger F., and Seeger W. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am. J. Physiol.: Heart Circ. Physiol. 283 (2002) H811-H818
12. Cuevas A.M., and Germain A.M. Diet and endothelial function. Biol. Res. 37 (2004) 225-230
13. Collie-Duguid E.S.R., and Wahle K.W.J. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun. 220 (1996) 969-974
14. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., Gallagher P.J., Calder P.C., and Grimble R.F. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003) 477-485
15. Kritchevsky D., Tepper S.A., Wright S., Czarnecki S.K., Wilson T.A., and Nicolosi R.J. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids 39 (2004) 611-616
16. Toomey S., Harhen B., Roche H.M., Fitzgerald D., and Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 187 1 (2006) 40-49
17. Fritsche J., and Steinhart H. Analysis, occurrence and physiological properties of trans fatty acids with particular emphasis on conjugated linoleic acid isomers (CLA). Fett/Lipid 100 (1998) 21-190
18. Choi Y., Park Y., Pariza M.W., and Ntambi J.M. Regulation of stearoyl-CoA Desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells. Biochem. Biophys. Res. Commun. 284 (2001) 689-693
19. Eder K., Schleser S., Becker K., and Korting R. Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. J. Nutr. 133 (2003) 4083-4089
20. Wahle K.J.W., and Rotondo D. Fatty acids and endothelial cell function: regulation of adhesion molecule and redox enzyme expression. Curr. Opin. Clin. Nutr. Metab. Care 2 (1999) 109-115
21. Wahle K.W.J., Heys S.D., and Rotondo D. Conjugated linoleic acids (CLAs): Are they beneficial or detrimental to health?. Progr. Lipid Res. 43 (2004) 553-587
22. Sakamoto H., Tosaki T., and Nakagawa Y. Overexpression of phospholipid hydroperoxide glutathione peroxidase modulates acetyl-CoA, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity. J. Biol. Chem. 277 (2002) 50431-50438
23. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
24. Goua M., Sneddon A.A., Mulgrew S., and Wahle K.W.J. ICAM-1 and VCAM-1 regulation by conjugated linoleic acid in human umbilical vein endothelial cells: involvement of the NF-κB pathway. Chem. Phys. Lipids 130 (2004) 38
25. Snyder F., Fitzgerald V., and Blank M.L. Biosynthesis of platelet-activating factor and enzyme inhibitors. Adv. Exp. Med. Biol. 416 (1996) 5-10
26. Poulos S.P., Sisk M., Hausman D.B., Azain M.J., and Hausman G.J. Pre- and postnatal dietary conjugated linoleic acid alters adipose development, body weight gain and body composition in Sprague-Dawley rats. J. Nutr. 131 10 (2001) 2722-2731
27. Lin X., Loor J.J., and Herbein J.H. Trans10,cis12-18:2 is a more potent inhibitor of de novo fatty acid synthesis and desaturation than cis9,trans11-18:2 in the mammary gland of lactating mice. J. Nutr. 134 6 (2004) 1362-1368
28. Thurberg B.L., and Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr. Opin. Lipidol. 9 (1998) 387-396
29. Imaizumi T., Itaya H., Fujita K., Kudoh D., Kudoh S., Mori K., Fujimoto K., Matsumiya T., Yoshida H., and Satoh K. Expression of tumor necrosis factor-In cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 410-415
30. Ranta V., Orpana A., Carpen O., Turpeinen U., Ylikorkala O., and Viinikka L. Human vascular endothelial cells produce tumor necrosis factor-In response to proinflammatory cytokine stimulation. Crit. Care Med. 27 (1999) 2184-2187
31. Yue T.L., Rabinovici R., Farhat M., and Feuerstein G. Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. Prostaglandins 39 (1990) 469-480
32. Terashita Z., Imura Y., Takatani M., Tsushima S., and Nishikawa K. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J. Pharmacol. Exp. Ther. 242 (1987) 263-268
33. Bussolino F., Camussi G., and Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J. Biol. Chem. 263 (1988) 11856-11861
34. Hill M.E., Bird I.N., Daniels R.H., Elmore M.A., and Finnen M.J. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers. J. Immunol. 153 8 (1994) 3673-3683
35. Kuijpers T.W., Hakkert B.C., Hoogerwerf M., Leeuwenberg J.F., and Roos D. Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation. J. Immunol. 147 4 (1991) 1369-1376
36. Dejana E., Breviario F., Erroi A., Bussolino F., Mussoni L., Gramse M., Pintucci G., Casali B., Dinarello C.A., Van Damme J., et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood 69 2 (1987) 695-699
37. Marcheselli V.L., Rossowska M., Domingo M.T., Braquet P., and Bazan N.G. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J. Biol. Chem. 265 (1990) 9140-9145
38. Bussolino F., and Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur. J. Biochem. 229 (1995) 327-337
39. Schleser S., Ringseis R., and Eder K. Conjugated linoleic acids have no effect on TNFalpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis 182 2 (2006) 337-344
40. Ringseis R., Müller A., Düsterloh K., Schleser S., Eder K., and Steinhart H. Formation of conjugated linoleic acid metabolites in human vascular endothelial cells. Biochim. Biophys. Acta 1761 3 (2006) 377-383
41. Park Y., Storkson J.M., Albright K.J., Liu W., and Pariza M.W. Biological activities of conjugated fatty acids: conjugated eicosadienoic (conj. 20:2delta(c11,t13/t12,c14)), eicosatrienoic (conj. 20:3delta(c8,t12,c14)), and heneicosadienoic (conj. 21:2delta(c12,t14/c13,t15)) acids and other metabolites of conjugated linoleic acid. Biochim. Biophys. Acta 1687 1-3 (2005) 120-129
42. Zimmerman G.A., Elstad M.R., Lorant D.E., McIntyre T.M., Prescott S.M., Topham M.K., Weyrich A.S., and Whatley R.E. Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. Platelet-activating factor and related lipid mediators 2. Advances in experimental medicine and biology. In: Nigham S., Kunkel G., and Prescott S.M. (Eds). Proceedings of the Fifth International Conference on Platelet-Activating Factor and Related Lipid Mediators vol. 416 (1996), Plenum, New York
43. Serhan C.H., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., and Moussignac R.-L. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196 (2002) 1025-1037